These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35548667)

  • 1. MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis.
    Wang L; Liang Y
    Front Mol Neurosci; 2022; 15():865529. PubMed ID: 35548667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    Piket E; Zheleznyakova GY; Kular L; Jagodic M
    J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, regulation and function of microRNAs in multiple sclerosis.
    Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
    Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in multiple sclerosis.
    Gao Y; Han D; Feng J
    Clin Chim Acta; 2021 May; 516():92-99. PubMed ID: 33545109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
    Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
    J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.
    Hecker M; Fitzner B; Putscher E; Schwartz M; Winkelmann A; Meister S; Dudesek A; Koczan D; Lorenz P; Boxberger N; Zettl UK
    EBioMedicine; 2022 Jun; 80():104052. PubMed ID: 35561450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.
    Fattahi M; Rezaei N; Nematalahi FS; Shaygannejad V; Fouladi S; Karimi L; Fathi F; Dehghani L; Mirmosayyeb O; Eskandari N
    Mult Scler Relat Disord; 2019 Oct; 35():241-245. PubMed ID: 31421628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
    Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
    Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-Dependent CD4
    Basak J; Majsterek I
    Mult Scler Int; 2021; 2021():8825588. PubMed ID: 33505725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.
    Chen C; Zhou Y; Wang J; Yan Y; Peng L; Qiu W
    Front Immunol; 2018; 9():1256. PubMed ID: 29915595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs involved in multiple sclerosis.
    Siegel SR; Mackenzie J; Chaplin G; Jablonski NG; Griffiths L
    Mol Biol Rep; 2012 May; 39(5):6219-25. PubMed ID: 22231906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders.
    Bai X; Bian Z
    Front Mol Neurosci; 2022; 15():842288. PubMed ID: 35173580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
    PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7188-5p and miR-7235 regulates Multiple sclerosis in an experimental mouse model.
    Ibrahim HM; AlZahrani A; Hanieh H; Ahmed EA; Thirugnanasambantham K
    Mol Immunol; 2021 Nov; 139():157-167. PubMed ID: 34543842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis.
    Franzoi AEA; de Moraes Machado FS; de Medeiros Junior WLG; Bandeira IP; Brandão WN; Gonçalves MVM
    Heliyon; 2021 Jun; 7(6):e07263. PubMed ID: 34179535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as active players in the pathogenesis of multiple sclerosis.
    Fenoglio C; Ridolfi E; Galimberti D; Scarpini E
    Int J Mol Sci; 2012 Oct; 13(10):13227-39. PubMed ID: 23202949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.
    Elkhodiry AA; Zamzam DA; El Tayebi HM
    Mult Scler Relat Disord; 2021 Aug; 53():103078. PubMed ID: 34171684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
    Mycko MP; Cichalewska M; Cwiklinska H; Selmaj KW
    J Neurosci; 2015 Dec; 35(50):16504-15. PubMed ID: 26674874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation.
    Honardoost MA; Naghavian R; Ahmadinejad F; Hosseini A; Ghaedi K
    Gene; 2015 Nov; 572(2):153-62. PubMed ID: 26307197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.
    Zhao M; Sun D; Guan Y; Wang Z; Sang D; Liu M; Pu Y; Fang X; Wang D; Huang A; Bi X; Cao L; He C
    J Neurosci; 2016 Aug; 36(35):9253-66. PubMed ID: 27581464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.